Cereno Scientific to attend BIO-Europe Spring in Barcelona, March 18–20, 2024
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that the company will attend BIO-Europe Spring in Barcelona, March 18–20, 2024.Sten R. Sörensen, Chief Executive Officer (CEO) at Cereno, will participate at the well-attended partnering event, bringing together biotech, pharma, investors, and other industry stakeholders. BIO-Europe Spring is the premier springtime partnering event connecting the global biopharma community, bringing together over 3,700 attendees from 2,000+ companies to